Alkem Laboratories has entered into a business transfer agreement with its wholly-owned subsidiary, Alkem Wellness, transferring its trade generics business effective October 1, 2025. Shares of Alkem Laboratories Ltd ended lower on Friday (September 26) by 1.72% at ₹5,413.50.
